These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18758789)

  • 1. Interleukin-13 exerts autocrine growth-promoting effects on human pancreatic cancer, and its expression correlates with a propensity for lymph node metastases.
    Formentini A; Prokopchuk O; Sträter J; Kleeff J; Grochola LF; Leder G; Henne-Bruns D; Korc M; Kornmann M
    Int J Colorectal Dis; 2009 Jan; 24(1):57-67. PubMed ID: 18758789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
    Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
    Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-32 expression in the pancreas.
    Nishida A; Andoh A; Inatomi O; Fujiyama Y
    J Biol Chem; 2009 Jun; 284(26):17868-76. PubMed ID: 19386602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.
    Sperveslage J; Frank S; Heneweer C; Egberts J; Schniewind B; Buchholz M; Bergmann F; Giese N; Munding J; Hahn SA; Kalthoff H; Klöppel G; Sipos B
    Int J Cancer; 2012 Aug; 131(4):E371-81. PubMed ID: 22020953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1alpha, 6 regulate the secretion of vascular endothelial growth factor A, C in pancreatic cancer.
    Tang RF; Wang SX; Zhang FR; Peng L; Wang SX; Xiao Y; Zhang M
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):460-3. PubMed ID: 16109537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
    Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
    Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node metastasis and the physicochemical micro-environment of pancreatic ductal adenocarcinoma xenografts.
    Andersen LMK; Wegner CS; Simonsen TG; Huang R; Gaustad JV; Hauge A; Galappathi K; Rofstad EK
    Oncotarget; 2017 Jul; 8(29):48060-48074. PubMed ID: 28624797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Wen Z; Liao Q; Zhao J; Hu Y; You L; Lu Z; Jia C; Wei Y; Zhao Y
    Ann Surg Oncol; 2014 Jan; 21(1):125-32. PubMed ID: 24132627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
    Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
    Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of glypican-1 expression with TGF-beta, BMP, and activin receptors in pancreatic ductal adenocarcinoma.
    Kayed H; Kleeff J; Keleg S; Jiang X; Penzel R; Giese T; Zentgraf H; Büchler MW; Korc M; Friess H
    Int J Oncol; 2006 Nov; 29(5):1139-48. PubMed ID: 17016645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
    Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G
    Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymosinalpha1 stimulates cell proliferation by activating ERK1/2, JNK, and increasing cytokine secretion in human pancreatic cancer cells.
    Li M; Feurino LW; Li F; Wang H; Zhai Q; Fisher WE; Chen C; Yao Q
    Cancer Lett; 2007 Apr; 248(1):58-67. PubMed ID: 16828224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of interleukin-4 and interleukin-13 and their receptors in colorectal cancer.
    Formentini A; Braun P; Fricke H; Link KH; Henne-Bruns D; Kornmann M
    Int J Colorectal Dis; 2012 Oct; 27(10):1369-76. PubMed ID: 22441356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8.
    Chen SJ; Lian GD; Li JJ; Zhang QB; Zeng LJ; Yang KG; Huang CM; Li YQ; Chen YT; Huang KH
    Cancer Med; 2018 Nov; 7(11):5679-5690. PubMed ID: 30311406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions.
    Prokopchuk O; Liu Y; Henne-Bruns D; Kornmann M
    Br J Cancer; 2005 Mar; 92(5):921-8. PubMed ID: 15714203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma.
    Guo J; Kleeff J; Zhao Y; Li J; Giese T; Esposito I; Büchler MW; Korc M; Friess H
    Int J Mol Med; 2006 May; 17(5):761-7. PubMed ID: 16596258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
    Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
    BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer.
    Kleeff J; Ishiwata T; Friess H; Büchler MW; Korc M
    Int J Cancer; 1998 Sep; 77(6):860-8. PubMed ID: 9714055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
    Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
    Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.